skip to main content

S. 2543: Prescription Drug Pricing Reduction Act of 2019

Call or Write Congress

An original bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes.

The bill’s titles are written by its sponsor.

Sponsor and status

Charles “Chuck” Grassley

Sponsor. Senior Senator for Iowa. Republican.

Read Text »
Last Updated: Sep 25, 2019
Length: 232 pages
Introduced
Sep 25, 2019
116th Congress (2019–2021)
Status

Ordered Reported on Sep 25, 2019

The committees assigned to this bill sent it to the House or Senate as a whole for consideration on September 25, 2019.

Prognosis
3% chance of being enacted according to Skopos Labs (details)
Source

Position statements

What legislators are saying

Grassley Statement on House Prescription Drug Bill CBO Score
    — Sen. Charles “Chuck” Grassley [R-IA] (Sponsor) on Oct 11, 2019

Rep. Schrader Introduces Bipartisan Bill to Improve Access to Gene Therapies
    — Rep. Kurt Schrader [D-OR5] on Feb 13, 2020

Brady, Walden, Foxx, Collins Push Bipartisan Plan to Lower Drug Costs
    — Rep. Kevin Brady [R-TX8] on Dec 11, 2019

More statements at ProPublica Represent...

What stakeholders are saying

R Street Institute SpendingTracker.org estimates S. 2543 will save $93.1 billion through 2030.

History

Sep 25, 2019
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Sep 25, 2019
 
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee. The Senate Committee on Finance issued the report which may provide insight into the purpose of the legislation.

If this bill has further action, the following steps may occur next:
 
Passed Senate

 
Passed House

 
Signed by the President

S. 2543 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number S. 2543. This is the one from the 116th Congress.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 2543 — 116th Congress: Prescription Drug Pricing Reduction Act of 2019.” www.GovTrack.us. 2019. October 29, 2020 <https://www.govtrack.us/congress/bills/116/s2543>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.